Systemic transcriptome analysis of hepatocellular carcinoma
- PMID: 27460080
- DOI: 10.1007/s13277-016-5286-5
Systemic transcriptome analysis of hepatocellular carcinoma
Abstract
Liver cancer is one of the most common malignant tumors, and most of which is hepatocellular carcinoma (HCC). We aim to study the characteristic changes of numerous genes and their roles in HCC through systematical analysis of the characteristics of expression spectrum of HCC. Firstly, we made systematic clustering of the HCC samples according to the RNAseq data from TCGA (The Cancer Genome Atlas) and newly classified HCC. Then the characteristic genes in different molecular subtypes were found out and further analyzed combing with methylation and SNP 6.0 chip. Finally, these genes were subjected to do functional annotation and abnormal signaling pathways of HCC in various molecular subtypes and were screened out. There were 3843 differential genes screened; among which, 689 genes were enriched into 13 KEGG-related pathways, and the expression of 27 and 924 genes showed positive and negative correlation to methylation level, respectively, while the expression of 43 genes showed positive correlation to variation level of copy number. The methylation degree of ZSCAN18 may be considered as a marker for prognosis evaluation, and ABHD6 could be a potential anti-oncogene.
Keywords: ABHD6; Hepatocellular carcinoma; Molecular classification; TCGA; ZSCAN18.
Similar articles
-
Prognostic implications of aberrantly expressed methylation‑driven genes in hepatocellular carcinoma: A study based on The Cancer Genome Atlas.Mol Med Rep. 2019 Dec;20(6):5304-5314. doi: 10.3892/mmr.2019.10771. Epub 2019 Oct 25. Mol Med Rep. 2019. PMID: 31661127
-
Comprehensive molecular and immunological characterization of hepatocellular carcinoma.EBioMedicine. 2019 Feb;40:457-470. doi: 10.1016/j.ebiom.2018.12.058. Epub 2018 Dec 29. EBioMedicine. 2019. PMID: 30598371 Free PMC article.
-
Expression pattern and prognostic value of N6-methyladenosine RNA methylation key regulators in hepatocellular carcinoma.Mutagenesis. 2021 Oct 6;36(5):369-379. doi: 10.1093/mutage/geab032. Mutagenesis. 2021. PMID: 34467992 Free PMC article.
-
Integrative analysis of aberrant Wnt signaling in hepatitis B virus-related hepatocellular carcinoma.World J Gastroenterol. 2015 May 28;21(20):6317-28. doi: 10.3748/wjg.v21.i20.6317. World J Gastroenterol. 2015. PMID: 26034368 Free PMC article. Review.
-
Genetic and epigenetic aspects of initiation and progression of hepatocellular carcinoma.World J Gastroenterol. 2015 Oct 7;21(37):10584-97. doi: 10.3748/wjg.v21.i37.10584. World J Gastroenterol. 2015. PMID: 26457018 Free PMC article. Review.
Cited by
-
Inactivation of ZSCAN18 by promoter hypermethylation drives the proliferation via attenuating TP53INP2-mediated autophagy in gastric cancer cells.Clin Epigenetics. 2023 Jan 17;15(1):10. doi: 10.1186/s13148-023-01425-9. Clin Epigenetics. 2023. PMID: 36650573 Free PMC article.
-
MicroRNAs as a Novel Tool in the Diagnosis of Liver Lipid Dysregulation and Fatty Liver Disease.Molecules. 2019 Jan 9;24(2):230. doi: 10.3390/molecules24020230. Molecules. 2019. PMID: 30634538 Free PMC article. Review.
-
Zinc finger and SCAN domain-containing protein 18 is a potential DNA methylation-modified tumor suppressor and biomarker in breast cancer.Front Endocrinol (Lausanne). 2023 May 8;14:1095604. doi: 10.3389/fendo.2023.1095604. eCollection 2023. Front Endocrinol (Lausanne). 2023. PMID: 37223020 Free PMC article.
-
Precision oncology in liver cancer.Ann Transl Med. 2018 Jul;6(14):285. doi: 10.21037/atm.2018.06.14. Ann Transl Med. 2018. PMID: 30105235 Free PMC article. Review.
-
Alpha/Beta-Hydrolase Domain-Containing 6: Signaling and Function in the Central Nervous System.Front Pharmacol. 2021 Dec 2;12:784202. doi: 10.3389/fphar.2021.784202. eCollection 2021. Front Pharmacol. 2021. PMID: 34925039 Free PMC article. Review.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical